Remove 2010 Remove Competition Remove Prospecting
article thumbnail

Navigating the Challenges of Biopharma Product Launches: A Blueprint for Success

PM360

The landscape is highly competitive with new prescription medications launching worldwide each year. Early shaping of the label during clinical trial design, risk mitigation, and avoiding approval delays are crucial for seizing a competitive advantage.

article thumbnail

CureVac gets an early date in Covid-19 vaccine patent case with Pfizer/BioNTech

Pharmaceutical Technology

In an August 2022 statement , Moderna stated its technology contained within patents filed between 2010 and 2016 was copied without permission. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Biopharma 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Although AbbVie will now face competition from these products, it has built a strong market for Humira, says Hlávka, adding that it will likely continue reporting significant revenues.

Marketing 104
article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Drift provides a conversational sales and marketing platform that allows businesses to better connect with prospects and customers. Founded 2010. Founded 2010. Founded 2010. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2014.

Sales 76
article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

article thumbnail

6 Crucial & Updated Medical Device Marketing Strategies

Healthcare Success

The Patient Protection and Affordable Care Act of 2010 has increased access to healthcare services for previously uninsured populations. Reach More Prospects with Search Engine Optimization. This placement allows medical device companies to share their strongest messages, promotions, or offers with new prospects.

Medical 65
article thumbnail

HSBC acquires SVB UK in strategic move to expand presence in biotech sector

Pharmaceutical Technology

According to GlobalData’s Pharma Intelligence Center Deals Database, figure 1 shows the parent holding company SVB Financial Group and its subsidiaries were involved in more than $1.4bn in total venture financing raised from 2010 to 2022 for drug development.